LOS ANGELES, Feb. 28, 2014 /PRNewswire/ — Verde Media Group Inc. (OTC: VMGI) has announced the formation of the Verde Media Biotechnology Division (“VMBD”).

The VMBD division will undertake the business of developing and producing high value bio-products from renewable biomass. The focus and criterion is to develop proprietary technologies with low risk of scale-up utilizing low cost feedstock. After successful production at demonstration scale such technologies and products will be licensed and sold to third parties globally.

VMBD will initially focus on two high value products with an over-lapping technology platform. First is the high density microbial production of Omega-3 oil. The market for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) Omega-3 products measured by global consumer spending on EPA/DHA fortified products was $25.4 billion in 2011 for the six following categories: infant formula; fortified foods and beverages; nutritional supplements; pharmaceuticals; clinical nutrition; and pet food, treats and supplements. The projected market value of EPA/ DHA Omega-3 products will reach $34.7 billion in 2016 with a continued accelerated growth rate over the next 5 years.

Secondly, the technology division will develop platform technologies for extracting highly purified forms of cannabis-based phytocannabinoids products, including D9 tetrahydrocannabinol (THC) and cannabidiol (CBD). VMBD will develop the derivative and ester forms of THC for increase potency and their use in different delivery systems, including sublingual, inhaled dosage forms and blending with food products.

The initial core team consists of experienced scientists and financial experts. Dr. Syed Hussain Abidi, Ph.D in biotechnology, from Oxford University, will lead the VMBD division as the Chief Executive Officer. Dr. Abidi has worked in the chemical engineering school at MIT and Harvard University and brings 10 years of experience in organism development and fermentation. He invented a microbial process of converting sugars to oil, similar to vegetable derived oil, used in the biofuel industry that lead to a series of high profile patents. Several of his patents have been successfully licensed to biotech companies both in the US and globally resulting in significant investment.

William Veve, President of Verde Media Group, Inc. stated, “We will scale the technologies developed, secure significant licence fees, and quickly bring products to market. With the leadership and proven track record of Dr. Abidi in biotech startups VMDB will be a substantial revenue generator.”

Syed Abidi, CEO of VMBD stated, “The microbial production of high value edible oils represent an exciting opportunity to “fill-in” the growing gap between increasing demand and greatly diminishing supply of existing fish derived omega-3 oils. The microbial-based omega-3 oils are sustainable and unique in that they also meet the quality standards for niche cosmetic and food applications. Our core platform technology of production, extraction and purification of omega-3 oil will also be instrumental for the medical marijuana oil market- where high degree of purification and sub-fractionation and product derivation is required for human consumption.”

The results described herein cannot be guaranteed. This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are “forward-looking statements” that are based on current expectations and assumptions.

SOURCE Verde Media Group, Inc.